ZEROKEY
ZeroKey today unveiled their second-generation technology, Quantum RTLS™, the world’s most accurate large-scale 3D real-time location system (RTLS). The technology enables unprecedented operational visibility of manufacturing , supply chain, logistics , and human-centric workflows to drive real-time optimization and integration of processes across entire organizations. Quantum RTLS ™ provides hyper-accurate digitization of the location of assets for closed-loop control of highly dynamic workflows, real-time monitoring of human-centric processes, process analytics, and high-fidelity digital twinning.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220601005976/en/
To perform data-driven decision-making, businesses must be able to derive actionable information from the data they are collecting, and that is where ZeroKey’s technology excels. The true value of a connected asset is unlocked through Quantum RTLS™ location technology, enabling an organization to make better-informed and more timely decisions. Through the digitization of both time and location, ZeroKey provides the highest level of accuracy and actionable analytics through its Spatial Intelligence Platform , giving customers 4D operational intelligence that truly delivers on the promise of Industry 4.0.
“The hyper accuracy of Quantum RTLS empowers companies to solve problems that have never been solved before in industrial environments,” says Matthew Lowe, CEO & Co-founder at ZeroKey. “Production efficiency and operational visibility are exponentially increased when operations are digitized in 4D with millimeter accuracy. Our technology enables unprecedented process optimization and quality control, allowing businesses to maximize their output while reducing costly errors.”
Features and benefits of Quantum RTLS™ include:
- Millimeter-level accuracy
- Real-time 3D tracking
- Operational visibility from a globally accessible platform
- Unprecedented analytics and digitization of physical processes
- Wide-area multi-floor/multi-room/multi-building scalability
- Rapid deployments with patented self-calibration technology
- Easy integration of third-party platforms through open API
Quantum RTLS™ will be available on June 30, 2022. For more information, visit https://www.zerokey.com/products/quantum-rtls .
About ZeroKey: ZeroKey’s patented technology, Quantum RTLS™, is the world’s only wide-area, 3D, millimeter-level RTLS technology that closes the IIoT utility gap in factories, warehouses, and industrial environments worldwide, including with six of the largest ten major automotive OEMs. Powered by ultrasonics, Quantum RTLS™ delivers high performance and reliability at any scale with unparalleled simplicity and flexibility. With a range of trackable tags suitable for diverse applications, ZeroKey technology tracks the assets, processes, goods, and personnel critical to modern business with unprecedented resolution. For more information, visit www.zerokey.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005976/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press release
Strategic collaboration to bring innovative residential solutions designed to reduce emissions and enable sustainable home heating Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press release
Visa Consulting & Analytics combines advanced payments strategy and expert crypto knowledge to help clients innovate and grow with stablecoins technology Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom